Population screening for cancer
146 results
101 - 146
Colonoscopy and FIT similar at population level; colonoscopy may be a bit better at individual level (COLONPREV)- Invitation to a single colonoscopy has only modest impact on colorectal cancer incidence (NordICC)
Personalised risk communication for informed decision making about taking screening tests: Cochrane systematic review- Rural Black women who are given the option of home HPV sampling are more likely to get screened
- Signs and symptoms can indicate an increase in the likelihood of ovarian cancer
- High adenoma detection rate during colonoscopy associated with lower incidence of colorectal cancer
Human papillomavirus (HPV) infection - Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults
- British guidelines for chronic diarrhea in adults
- Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income countries
- Myositis
- Multicancer early detection numbers needed to screen: 1000 to detect one stage 1 or 2 cancer, 530 to detect any cancer (SPOT-MAS)
- Water infusion versus air insufflation for colonoscopy: Cochrane systematic review
- Incidence of complications after conization of the uterine cervix
- Lynch syndrome
- Second-generation fecal DNA plus FIT test is more sensitive and specific, but no mortality data (BLUE-C)
- Virtual colonoscopy avoids the need for bowel prep
- Guaiac‐based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average‐risk individuals
- Palliative interventions for controlling vaginal bleeding in advanced cervical cancer
- Postoperative tamoxifen for ductal carcinoma in situ
- Evaluation of thrombophilia
- Exercise for reducing falls in people living with and beyond cancer: Cochrane systematic review
- Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer
- Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
- Value of surveillance in patients with low-risk polyps is uncertain
- Interventions for anal canal intraepithelial neoplasia
- Clinical, functional, and demographic factors predict 10-year mortality in adults older than 50
- Risk‐reducing mastectomy for the prevention of primary breast cancer
- Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients
- Localization techniques for guided surgical excision of non‐palpable breast lesions
- Government regulation of private health insurance
- Rare endocrine tumours
- Behavioural activation therapy for depression in adults with non‐communicable diseases
- Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people
- Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units
- Chemotherapy for advanced gastric cancer
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
- Peptic ulcer disease, Helicobacter pylori infection and chronic gastritis
- Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
- Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules
- Interactive telemedicine: effects on professional practice and health care outcomes
- Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes